Endocyte Inc (ECYT.OQ)
ECYT.OQ on NASDAQ Stock Exchange Global Select Market
18.36USD
1 Aug 2013
18.36USD
1 Aug 2013
Price Change (% chg)
$0.39 (+2.17%)
$0.39 (+2.17%)
Prev Close
$17.97
$17.97
Open
$18.12
$18.12
Day's High
$18.41
$18.41
Day's Low
$18.12
$18.12
Volume
7,969
7,969
Avg. Vol
77,521
77,521
52-wk High
$18.41
$18.41
52-wk Low
$7.50
$7.50
About
Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its technology to create small molecule drug conjugates (SMDCs), and companion imaging diagnostics. Its SMDCs target receptors that are over-expressed on... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $646.43 |
| Shares Outstanding (Mil.): | 35.97 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ECYT.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.32 | -- | -- |
| ROI: | -8.98 | -2.58 | 18.76 |
| ROE: | -11.30 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Sanofi SA (SASY.PA) | €76.87 | -3.30 |
| Eli Lilly & Co. (LLY.N) | $53.17 | +0.06 |
| Nektar Therapeutics (NKTR.OQ) | $11.32 | +0.11 |
| Sunesis Pharmaceuticals, Inc. (SNSS.OQ) | $5.14 | +0.06 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

